Fiduciary Planning’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.1M Buy
4,498
+5
+0.1% +$1.17K 0.33% 34
2025
Q4
$930K Buy
4,493
+6
+0.1% +$1.19K 0.28% 37
2025
Q3
$832K Buy
4,487
+294
+7% +$50.4K 0.25% 44
2025
Q2
$641K Buy
4,193
+8
+0.2% +$1.23K 0.21% 47
2025
Q1
$694K Buy
4,185
+7
+0.2% +$1.09K 0.23% 46
2024
Q4
$604K Sell
4,178
-37
-0.9% -$5.73K 0.2% 48
2024
Q3
$683K Buy
4,215
+40
+1% +$6.37K 0.23% 41
2024
Q2
$610K Buy
4,175
+8
+0.2% +$1.19K 0.22% 40
2024
Q1
$659K Buy
4,167
+7
+0.2% +$1.11K 0.25% 37
2023
Q4
$652K Buy
4,160
+1
+0% +$153 0.28% 33
2023
Q3
$648K Buy
4,159
+804
+24% +$133K 0.31% 46
2023
Q2
$555K Buy
3,355
+1
+0% +$161 0.26% 34
2023
Q1
$520K Buy
3,354
+1
+0% +$161 0.25% 34
2022
Q4
$592K Buy
3,353
+1
+0% +$173 0.29% 34
2022
Q3
$548K Sell
3,352
-167
-5% -$28.3K 0.28% 30
2022
Q2
$625K Sell
3,519
-81
-2% -$14.4K 0.31% 30
2022
Q1
$638K Sell
3,600
-1,060
-23% -$180K 0.35% 29
2021
Q4
$797K Sell
4,660
-414
-8% -$67.8K 0.45% 26
2021
Q3
$819K Sell
5,074
-4,355
-46% -$743K 0.44% 34
2021
Q2
$1.55M Sell
9,429
-2,947
-24% -$488K 1.34% 16
2021
Q1
$2.03M Sell
12,376
-598
-5% -$96.8K 3.07% 9
2020
Q4
$2.04M Buy
12,974
+413
+3% +$60.9K 2.88% 7
2020
Q3
$1.87M Buy
12,561
+716
+6% +$106K 3.08% 6
2020
Q2
$1.73M Buy
11,845
+457
+4% +$66.6K 3.8% 5
2020
Q1
$1.49M Buy
11,388
+7,237
+174% +$1.03M 2.8% 8
2019
Q4
$621K Buy
+4,151
New +$563K 0.57% 29

Other funds holding JNJ

Fiduciary Planning's JNJ Position: Q1 2026 in Review

Fiduciary Planning increased its Johnson & Johnson (JNJ) stake by 0.11% in Q1 2026, buying an estimated $1.17K and bringing the position to 4,498 shares worth $1.1M. The position accounts for 0.33% of the portfolio, ranked #34.

Fiduciary Planning first reported a position in JNJ in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.04M in Q4 2020. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Fiduciary Planning held 4,498 shares of Johnson & Johnson worth $1.1M as of Q1 2026.
  • Fiduciary Planning bought 5 Johnson & Johnson shares in Q1 2026, an estimated $1.17K.
  • Johnson & Johnson made up 0.33% of Fiduciary Planning's portfolio in Q1 2026, its #34 holding.
  • Fiduciary Planning first reported a position in Johnson & Johnson in Q4 2019 and has held it in 26 quarters since.
  • Fiduciary Planning's Johnson & Johnson position peaked at $2.04M in Q4 2020.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Fiduciary Planning's 13F filing for Q1 2026, filed 27 Apr 2026.